Matches in Wikidata for { <http://www.wikidata.org/entity/Q58659526> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q58659526 description "im November 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58659526 description "wetenschappelijk artikel" @default.
- Q58659526 description "наукова стаття, опублікована в листопаді 2012" @default.
- Q58659526 name "Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide" @default.
- Q58659526 name "Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide" @default.
- Q58659526 type Item @default.
- Q58659526 label "Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide" @default.
- Q58659526 label "Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide" @default.
- Q58659526 prefLabel "Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide" @default.
- Q58659526 prefLabel "Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide" @default.
- Q58659526 P1433 Q58659526-F0D8BF45-5E23-4B4A-9980-296AE4768C6D @default.
- Q58659526 P1476 Q58659526-525800AE-2AE0-4B5C-836E-01F7B2DAFF76 @default.
- Q58659526 P2093 Q58659526-112582F3-9E03-4521-A4BB-25B9F2E070E5 @default.
- Q58659526 P2093 Q58659526-31923DDB-8D25-4B79-8472-0B513BBC452F @default.
- Q58659526 P2093 Q58659526-34B754DF-E126-4EA5-BB02-A59E8622AAC2 @default.
- Q58659526 P2093 Q58659526-37EDE0D5-2375-4E7E-BD73-4657917B3CFF @default.
- Q58659526 P2093 Q58659526-58438414-8AF6-4A41-9AD1-5B18CF378C69 @default.
- Q58659526 P2093 Q58659526-A358DE40-10AB-42F5-B818-A5399141CC49 @default.
- Q58659526 P2093 Q58659526-D59ED22C-4E48-42E0-9604-1F0FAF4BB852 @default.
- Q58659526 P2093 Q58659526-E3FD3FA5-2D26-4316-A184-FEBB6D89EC7C @default.
- Q58659526 P2093 Q58659526-E6356183-23B7-4B36-90D6-0F1F79A7692D @default.
- Q58659526 P2093 Q58659526-FA974CA5-CB33-4237-BE5A-C6416CF8DC14 @default.
- Q58659526 P2860 Q58659526-0A2E98E4-058E-4347-8614-017B68072217 @default.
- Q58659526 P2860 Q58659526-0FD0284C-8AAC-45F3-8DB6-74682514500E @default.
- Q58659526 P2860 Q58659526-4308766C-BD7E-4F9B-A1C5-B280FCC38261 @default.
- Q58659526 P2860 Q58659526-544AA6DF-B716-404C-92C3-84E12FB8A7C9 @default.
- Q58659526 P2860 Q58659526-5EA5FDB3-C3A9-4FBB-82BA-B4304153CABF @default.
- Q58659526 P2860 Q58659526-7DC9FFCD-81F7-4323-8CBC-2BA5C4F0A21D @default.
- Q58659526 P2860 Q58659526-CAAFAE11-F909-49E7-8EBB-A1E6776C257A @default.
- Q58659526 P2860 Q58659526-D0C34F17-41D1-4996-9366-39E0698D503F @default.
- Q58659526 P2860 Q58659526-D8C9620D-8604-4D20-8204-D9F809C66D46 @default.
- Q58659526 P2888 Q58659526-34FECDB2-E949-410B-B162-136C7976FE7C @default.
- Q58659526 P31 Q58659526-D743D115-473E-4305-A9BD-A0E0CF2BE975 @default.
- Q58659526 P356 Q58659526-0AE1A990-4ED5-412E-9D6D-B0CA9899FFE2 @default.
- Q58659526 P577 Q58659526-6937C073-D5D7-429B-8637-67146735EDE6 @default.
- Q58659526 P921 Q58659526-327746E6-D4A0-4FE9-8A55-C86DB44BC3D7 @default.
- Q58659526 P356 S10165-012-0792-9 @default.
- Q58659526 P1433 Q15752709 @default.
- Q58659526 P1476 "Serum levels of anti-SRP54 antibodies reflect disease activity of necrotizing myopathy in a child treated effectively with combinatorial methylprednisolone pulses and plasma exchanges followed by intravenous cyclophosphamide" @default.
- Q58659526 P2093 "Fabienne Jouen" @default.
- Q58659526 P2093 "Laurent Drouot" @default.
- Q58659526 P2093 "Masako Kikuchi" @default.
- Q58659526 P2093 "Mei Momomura" @default.
- Q58659526 P2093 "Olivier Boyer" @default.
- Q58659526 P2093 "Shumpei Yokota" @default.
- Q58659526 P2093 "Takako Miyamae" @default.
- Q58659526 P2093 "Tomo Nozawa" @default.
- Q58659526 P2093 "Tomoyuki Imagawa" @default.
- Q58659526 P2093 "Toshitaka Kizawa" @default.
- Q58659526 P2860 Q33844947 @default.
- Q58659526 P2860 Q33975216 @default.
- Q58659526 P2860 Q35550062 @default.
- Q58659526 P2860 Q37849951 @default.
- Q58659526 P2860 Q40154248 @default.
- Q58659526 P2860 Q41587406 @default.
- Q58659526 P2860 Q48604113 @default.
- Q58659526 P2860 Q54270054 @default.
- Q58659526 P2860 Q58659611 @default.
- Q58659526 P2888 s10165-012-0792-9 @default.
- Q58659526 P31 Q13442814 @default.
- Q58659526 P356 "10.1007/S10165-012-0792-9" @default.
- Q58659526 P577 "2012-11-03T00:00:00Z" @default.
- Q58659526 P921 Q417222 @default.